查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587457

腺结合病毒载体製造市场规模、份额、趋势分析报告：2025-2030年按业务规模、方法、治疗领域、应用、地区和细分市场预测

Adeno Associated Virus Vector Manufacturing Market Size, Share & Trends Analysis Report By Scale Of Operations (Clinical, Preclinical, Commercial), By Method, By Therapeutic Area, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

腺结合病毒载体製造市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球腺结合病毒载体製造市场规模将达27.8亿美元，2025年至2030年复合年增长率为18.55%。

这种增长是由于癌症、囊肿纤维化、Duchenne氏肌肉失养症和色素性视网膜炎等慢性疾病的盛行率不断增加所致。腺结合病毒（AAV）载体在这些疾病的治疗中发挥重要作用。 AAV 载体也广泛应用于基因治疗传递。每家公司都致力于联合研究、合併和联盟，随着研发的进展将创新产品推向市场。

例如，2021年12月， Astellas Pharma 和 Dyno Therapeutics 达成策略合作，利用 Dyno 的 CapsidMap 平台开发基于 NGS 的 AAV 载体，用于心臟和骨骼肌的基因治疗。这些努力预计将扩大我们在抗体开发和生产市场的影响力，并有望支持市场成长。 COVID-19 大流行对该行业产生了积极影响。由于腺结合病毒在疫苗生产中具有广泛的应用，因此多家公司已加入生产治疗 COVID-19 疫苗的竞赛。结果，製造这些载体的需求激增。

例如，2021年9月，CEVEC与UCB签署策略协议，使用ELEVECTA AAV载体製造技术进行研发与基因治疗应用。由于基因治疗涉及修改基因，因此存在许多伦理问题。因此，美国政府限制了联邦资金用于种系基因治疗研究的使用。基因疗法可以帮助您家庭的后代避免患有某些遗传疾病。然而，预计它会对胎儿发育产生重大影响。对疫苗、基因治疗药物、CGMP 药物、治疗和治愈急性疾病的产品的高需求以及对改善患者照护的需求也在推动行业增长。因此，全球相关人员正在进行大量投资以扩大产能，以满足不断增长的需求。

腺结合病毒载体製造市场报告亮点

  • 从业务规模来看，2024年商业领域将占据产业主导地位。由于企业加大研发投入以及疫苗生产商的需求。
  • 由于慢性神经退化性疾病的高盛行率以及腺结合病毒载体的疗法治疗这些疾病的功效，神经系统疾病治疗领域在 2024 年占据最大份额。
  • 疫苗被认为是一个主要应用领域，在 2024 年占收益占有率，并且由于对疫苗治疗的需求不断增长以及疫苗生产的投资和资金可能会持续增加，因此在整个预测期内将保持主导地位。
  • 北美已确立了强大的区域地位。随着该地区的公司开发产品，癌症发病率的上升和研发成本的上升正在推动该地区的市场。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场趋势及展望
    • 市场动态
    • 市场限制因素分析
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19 影响分析

第四章 业务规模分析

  • 企业规模细分仪表板
  • 全球腺结合病毒载体製造市场：业务规模波动分析
  • 2018-2030年全球腺结合病毒载体製造市场规模及趋势分析（依业务规模）
  • 临床
    • 临床市场，2018-2030
  • 临床前
    • 临床前市场，2018-2030
  • 商业的
    • 商业市场，2018-2030

第五章业务分析方法

  • 方法细分仪表板
  • 全球腺结合病毒载体製造市场：方法变异分析
  • 2018-2030年全球腺结合病毒载体製造市场规模及趋势分析（依方法）
  • In Vitro
    • 体外市场，2018-2030
  • In Vivo
    • 体内市场，2018-2030

第六章 治疗领域业务分析

  • 治疗区域细分仪表板
  • 全球腺结合病毒载体生产市场：治疗领域波动分析
  • 2018-2030年全球腺结合病毒载体製造市场规模及趋势分析（依治疗领域）
  • 血液疾病
    • 血液疾病市场，2018-2030
  • 感染疾病
    • 感染疾病市场，2018-2030
  • 遗传疾病
    • 遗传疾病市场，2018-2030
  • 神经系统疾病
    • 神经系统疾病市场，2018-2030
  • 眼科疾病
    • 2018-2030年眼科疾病市场
  • 其他的
    • 其他市场，2018-2030

第七章 应用业务分析

  • 使用细分仪表板
  • 全球腺结合病毒载体製造市场：应用变异分析
  • 2018-2030年全球腺结合病毒载体製造市场规模及趋势分析（按应用）
  • 细胞疗法
    • 细胞治疗市场，2018-2030
  • 基因治疗
    • 基因治疗市场，2018-2030
  • 疫苗
    • 疫苗市场，2018-2030

第八章区域业务分析

  • 区域仪表板
  • 2018-2030年市场规模及预测及趋势分析
  • 北美洲
    • 北美腺结合病毒载体製造市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲腺结合病毒载体製造市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区腺结合病毒载体製造市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲腺结合病毒载体製造市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东及非洲腺结合病毒载体製造市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 参与企业
  • 策略规划
  • 2024 年企业市场分析
  • 参与企业概况
    • F. Hoffmann-La Roche Ltd
    • Charles River Laboratories
    • Oxford Biomedica PLC
    • WuXi AppTec
    • Yposkesi, Inc.
    • Sarepta Therapeutics, Inc.
    • Pfizer Inc.
    • Genezen
    • Creative Biogene
    • GenScript（ProBio）
Product Code: GVR-4-68040-037-5

Adeno Associated Virus Vector Manufacturing Market Growth & Trends:

The global adeno associated virus vector manufacturing market size is expected to reach USD 2.78 billion by 2030, registering a CAGR of 18.55% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to the increasing prevalence of chronic diseases like cancers, cystic fibrosis, Duchenne muscular dystrophy, retinitis pigmentosa, and many more. Adeno-associated virus (AAV) vector plays a vital role in the treatment of these diseases. AAV vectors also have a wide range of applications in gene therapy delivery. Companies are engaged in collaborations, mergers, and partnerships for innovative product launches with advancements in R&D.

For instance, in December 2021, Astellas and Dyno Therapeutics entered into a strategic collaboration to develop an NGS-based AAV vector for gene therapy by using Dyno's CapsidMap platform for cardiac and skeletal muscle. Such initiatives are expected to expand their market presence in the development and production of antibodies, which is likely to support the growth of the market. The COVID-19 pandemic had a positive impact on the industry. As adeno associated virus has vast applications in vaccine manufacturing, various companies were involved in the race to manufacture the vaccine to treat COVID-19. This resulted in a sudden spur in the demand for manufacturing these vectors.

For instance, in September 2021, CEVEC and UCB entered into a strategic agreement for the use of ELEVECTA AAV vector manufacturing technology for R&D and gene therapy applications. As gene therapy involves alterations or modifications in the set of genes, it has raised many ethical issues. As a result, the U.S. government restricted the usage of federal funds for research on germline gene therapy in people. Gene therapy can help save future generations of a family from acquiring a particular genetic disorder. However, it is anticipated to affect the fetus's development significantly. The high demand for vaccines, gene therapeutics, CGMP drugs, and products to treat & cure acute diseases and the demand for improving patient care also propel the industry growth. Thus, global stakeholders are investing significantly in expanding their production capacities to fulfill the growing demands.

Adeno Associated Virus Vector Manufacturing Market Report Highlights:

  • By the scale of operations, the commercial segment dominated the industry in 2024. Owing to the increasing R&D investment by companies and demand from vaccine manufacturers
  • The neurological diseases therapeutic area segment captured the largest share in 2024 due to the high prevalence of chronic neurodegenerative diseases and the effectiveness of the adeno associated virus vector-based therapies to treat these diseases
  • Vaccine is considered a key application segment, which held the largest revenue share in 2024 and is likely to remain dominant throughout the forecast period due to the rising demand for vaccine therapeutics and increasing investments & funds for the production of vaccines
  • North America has established a strong regional position. The increasing incidence of cancer and high R&D expenditure is encouraging companies in the region to undertake product development, which drives the regional market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Scale of Operations
    • 1.2.2. Method
    • 1.2.3. Therapeutic Area
    • 1.2.4. Application
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
    • 3.2.1. Market Dynamics
      • 3.2.1.1. Technological advancements in manufacturing vectors
      • 3.2.1.2. Robust pipelines for gene therapies and vaccines
      • 3.2.1.3. Increasing number of emerging players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory, scientific and ethical challenges
      • 3.2.2.2. Production capacity challenges
  • 3.3. Business Environment Analysis
    • 3.3.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.3.2. Porter's Five Forces Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Scale Of Operations Business Analysis

  • 4.1. Scale of Operations Segment Dashboard
  • 4.2. Global Adeno Associated Virus Vector Manufacturing Market: Scale of Operations Movement Analysis
  • 4.3. Global Adeno Associated Virus Vector Manufacturing Market Size & Trend Analysis, by Scale of Operations, 2018 to 2030 (USD Million)
  • 4.4. Clinical
    • 4.4.1. Clinical Market, 2018 - 2030 (USD Million)
  • 4.5. Preclinical
    • 4.5.1. Preclinical Market, 2018 - 2030 (USD Million)
  • 4.6. Commercial
    • 4.6.1. Commercial Market, 2018 - 2030 (USD Million)

Chapter 5. Method Business Analysis

  • 5.1. Method Segment Dashboard
  • 5.2. Global Adeno Associated Virus Vector Manufacturing Market: Method Movement Analysis
  • 5.3. Global Adeno Associated Virus Vector Manufacturing Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 5.4. In Vitro
    • 5.4.1. In Vitro Market, 2018 - 2030 (USD Million)
  • 5.5. In Vivo
    • 5.5.1. In Vivo Market, 2018 - 2030 (USD Million)

Chapter 6. Therapeutic Area Business Analysis

  • 6.1. Therapeutic Area Segment Dashboard
  • 6.2. Global Adeno Associated Virus Vector Manufacturing Market: Therapeutic Area Movement Analysis
  • 6.3. Global Adeno Associated Virus Vector Manufacturing Market Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 6.4. Hematological Diseases
    • 6.4.1. Hematological Diseases Market, 2018 - 2030 (USD Million)
  • 6.5. Infectious Diseases
    • 6.5.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 6.6. Genetic Disorders
    • 6.6.1. Genetic Disorders Market, 2018 - 2030 (USD Million)
  • 6.7. Neurological Disorders
    • 6.7.1. Neurological Disorders Market, 2018 - 2030 (USD Million)
  • 6.8. Ophthalmic Disorders
    • 6.8.1. Ophthalmic Disorders Market, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Adeno Associated Virus Vector Manufacturing Market: Application Movement Analysis
  • 7.3. Global Adeno Associated Virus Vector Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Cell Therapy
    • 7.4.1. Cell Therapy Market, 2018 - 2030 (USD Million)
  • 7.5. Gene Therapy
    • 7.5.1. Gene Therapy Market, 2018 - 2030 (USD Million)
  • 7.6. Vaccine
    • 7.6.1. Vaccine Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. U.S. Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Canada Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Mexico Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Germany Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. UK Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. France Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Italy Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Spain Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Denmark Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Sweden Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Target Disease Prevalence
      • 8.4.9.3. Competitive Scenario
      • 8.4.9.4. Regulatory Framework
      • 8.4.9.5. Norway Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Japan Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. China Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. India Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. South Korea Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Regulatory Framework
      • 8.5.6.5. Australia Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Regulatory Framework
      • 8.5.7.5. Thailand Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Brazil Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Argentina Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Regulatory Framework
      • 8.7.2.5. South Africa Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Regulatory Framework
      • 8.7.3.5. Saudi Arabia Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Target Disease Prevalence
      • 8.7.4.3. Competitive Scenario
      • 8.7.4.4. Regulatory Framework
      • 8.7.4.5. UAE Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Target Disease Prevalence
      • 8.7.5.3. Competitive Scenario
      • 8.7.5.4. Regulatory Framework
      • 8.7.5.5. Kuwait Adeno Associated Virus Vector Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Participant's Overview
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Service Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Charles River Laboratories
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Service Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Oxford Biomedica PLC
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Service Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. WuXi AppTec
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Yposkesi, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Sarepta Therapeutics, Inc.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Pfizer Inc.
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Genezen
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Creative Biogene
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. GenScript (ProBio)
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 3 Global adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 4 Global adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 6 Global adeno associated virus vector manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 9 North America adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 10 North America adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 12 U.S. adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 13 U.S. adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 14 U.S. adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 16 Canada adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 17 Canada adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 18 Canada adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 20 Mexico adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 21 Mexico adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Mexico adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 24 Europe adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 26 Europe adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 27 Europe adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 29 UK adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 30 Europe adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 31 UK adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 33 Germany adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 34 Germany adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 35 Germany adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Germany adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 37 France adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 38 France adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 39 France adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 40 France adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 41 Italy adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 42 Italy adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 43 Italy adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 45 Spain adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 46 Spain adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 47 Spain adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 49 Denmark adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 50 Denmark adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 51 Denmark adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 53 Sweden adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 54 Sweden adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 55 Sweden adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 57 Norway adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 58 Norway adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 59 Norway adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 66 Japan adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 67 Japan adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 68 Japan adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 70 China adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 71 China adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 72 China adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 73 China adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 74 India adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 75 India adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 76 India adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 77 India adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 78 Australia adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 79 Australia adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 80 Australia adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 82 Thailand adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 83 Thailand adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 84 Thailand adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 86 South Korea adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 87 South Korea adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 88 South Korea adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 89 South Korea adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 90 Latin America adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 92 Latin America adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 93 Latin America adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 95 Brazil adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 96 Brazil adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 97 Brazil adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 99 Argentina adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 100 Argentina adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 101 Argentina adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 103 Middle East and Africa adeno associated virus vector manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 104 Middle East and Africa adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 105 Middle East and Africa adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 106 Middle East and Africa adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 107 Middle East and Africa adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 108 South Africa adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 109 South Africa adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 110 South Africa adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 116 UAE adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 117 UAE adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 118 UAE adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)
  • Table 120 Kuwait adeno associated virus vector manufacturing market, by scale of operations, 2018 - 2030 (USD Million)
  • Table 121 Kuwait adeno associated virus vector manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 122 Kuwait adeno associated virus vector manufacturing market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait adeno associated virus vector manufacturing market, by method, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Adeno associated virus vector manufacturing market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Global adeno associated virus vector manufacturing market: mode movement analysis
  • Fig. 16 Global adeno associated virus vector manufacturing market, for in vitro, 2018 - 2030 (USD Million)
  • Fig. 17 Global adeno associated virus vector manufacturing market, for in vivo, 2018 - 2030 (USD Million)
  • Fig. 18 Global adeno associated virus vector manufacturing market: scale of operations movement analysis
  • Fig. 19 Global adeno associated virus vector manufacturing market, for clinical, 2018 - 2030 (USD Million)
  • Fig. 20 Global adeno associated virus vector manufacturing market, for preclinical, 2018 - 2030 (USD Million)
  • Fig. 21 Global adeno associated virus vector manufacturing market, for commercial, 2018 - 2030 (USD Million)
  • Fig. 22 Global adeno associated virus vector manufacturing market: therapeutic area movement analysis
  • Fig. 23 Global adeno associated virus vector manufacturing market, for haematological diseases, 2018 - 2030 (USD Million)
  • Fig. 24 Global adeno associated virus vector manufacturing market, for infectious diseases, 2018 - 2030 (USD Million)
  • Fig. 25 Global adeno associated virus vector manufacturing market, for genetic disorders, 2018 - 2030 (USD Million)
  • Fig. 26 Global adeno associated virus vector manufacturing market, for neurological disorders, 2018 - 2030 (USD Million)
  • Fig. 27 Global adeno associated virus vector manufacturing market, for ophthalmic disorders, 2018 - 2030 (USD Million)
  • Fig. 28 Global adeno associated virus vector manufacturing market, for others, 2018 - 2030 (USD Million)
  • Fig. 29 Global adeno associated virus vector manufacturing market: application movement analysis
  • Fig. 30 Global adeno associated virus vector manufacturing market, for cell therapy, 2018 - 2030 (USD Million)
  • Fig. 31 Global adeno associated virus vector manufacturing market, for gene therapy, 2018 - 2030 (USD Million)
  • Fig. 32 Global adeno associated virus vector manufacturing market, for vaccine, 2018 - 2030 (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 Regional outlook, 2024 & 2030
  • Fig. 35 Global adeno associated virus vector manufacturing market: region movement analysis
  • Fig. 36 North America adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 UK adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 43 France adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia pacific adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 51 China adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 52 India adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait adeno associated virus vector manufacturing market, 2018 - 2030 (USD Million)